Abstracts
Showing 44 abstracts.
Effect of Pregnancy on Pharmacokinetics of Boosted Indinavir
Conference
13th International Workshop on Clinical Pharmacology of HIV Therapy
Study
P1026S
Pharmacokinetics of Increased Dose Atazanavir with and without Tenofovir During Pregnancy
Conference
12th International Workshop on Clinical Pharmacology of HIV Therapy
Study
P1026S
Efavirenz Pharmacokinetics during the 3rd Trimester of Pregnancy and Postpartum
Conference
18th Conference on Retroviruses & Opportunistic Infections
Study
P1026S
Raltegravir Pharmacokinetics during Pregnancy
Conference
50th Interscience Conference on Antimicrobial Agents and Chemotherapy
Study
P1026S
Boosted FosAmprenavir Pharmacokinetics During Pregnancy
Conference
17th Conference on Retroviruses & Opportunistic Infections
Study
P1026S
Authors
Edmund Capparelli, Alice M. Stek, Brookie M. Best, Stephen J. Rossi, Sandra K. Burchett, Haihong Li, Jennifer S. Read, Elizabeth (Betsy) Smith, Elizabeth Hawkins, Michael T. Basar, Mark MirochnickHigh-dose lopinavir and standard-dose emtricitabine pharmacokinetics during pregnancy and postpartum.
Conference
15th Conference on Retroviruses & Opportunistic Infections
Study
P1026S
Authors
Brookie M. Best, Alice M. Stek, ChengCheng Hu, Sandra K. Burchett, Steven Rossi, Elizabeth (Betsy) Smith, Jennifer S. Read, Edmund Capparelli, Mark MirochnickTenofovir pharmacokinetics during pregnancy, at delivery and postpartum.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1026S
Authors
Sandra K. Burchett, Brookie M. Best, Mark Mirochnick, ChengCheng Hu, Edmund Capparelli, Diane Holland, Elizabeth (Betsy) Smith, Jennifer S. Read, Alice M. StekNelfinavir pharmacokinetics (625 mg tablets) during the third trimester of pregnancy and post-partum.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1026S
Authors
Jennifer S. Read, Brookie M. Best, Alice M. Stek, ChengCheng Hu, Edmund Capparelli, Diane Holland, Sandra K. Burchett, Elizabeth (Betsy) Smith, Mark MirochnickLopinavir protein binding during pregnancy.
Conference
14th Conference on Retroviruses and Opportunistic Infections
Study
P1026S
Authors
Francesca Aweeka, Alice M. Stek, Brookie M. Best, ChengCheng Hu, Diane Holland, Ashwaq E. Hermes, Sandra K. Burchett, Jennifer S. Read, Mark Mirochnick, Edmund CapparelliAdequate lopinavir exposure achieved with a higher dose during the 3rd trimester of pregnancy.
Conference
13th Conference on Retroviruses and Opportunistic Infections
Study
P1026S